Marit Hellebostad
- Public Health, Environmental and Occupational Health top 5%
- Hematology top 2%
- Pediatrics, Perinatology and Child Health top 5%
- Oncology
- Molecular Biology
- Co-authors
- Erik ForestierKjeld SchmiegelowMats HeymanS SöderhällMervi TaskinenJakob KristinssonP HågåÓlafur G. Jónsson
- Topics
- Acute Lymphoblastic Leukemia research (13 papers)Childhood Cancer Survivors' Quality of Life (10 papers)Acute Myeloid Leukemia Research (7 papers)
In The Last Decade
Marit Hellebostad
35 papers receiving 910 citations
Peers
Comparison fields: 5 of 82
- Public Health, Environmental and Occupational Health 475
- Hematology 413
- Pediatrics, Perinatology and Child Health 389
- Oncology 160
- Molecular Biology 134
Countries citing papers authored by Marit Hellebostad
This map shows the geographic impact of Marit Hellebostad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marit Hellebostad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marit Hellebostad more than expected).
Fields of papers citing papers by Marit Hellebostad
This network shows the impact of papers produced by Marit Hellebostad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marit Hellebostad. The network helps show where Marit Hellebostad may publish in the future.
Co-authorship network of co-authors of Marit Hellebostad
This figure shows the co-authorship network connecting the top 25 collaborators of Marit Hellebostad. A scholar is included among the top collaborators of Marit Hellebostad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marit Hellebostad. Marit Hellebostad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 9 | |
| 3 | 113 | |
| 4 | 5 | |
| 5 | 4 | |
| 6 | 5 | |
| 7 | 17 | |
| 8 | EDUCATIONAL REPORT Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia | 0 |
| 9 | 272 | |
| 10 | 14 | |
| 11 | 21 | |
| 12 | 34 | |
| 13 | Cellular drug sensitivity in MLL-rearranged childhood acute leukemia is correlated to partner genes and cell lineage : On behalf of the Nordic Society for Paediatric Haematology and Oncology | 1 |
| 14 | 24 | |
| 15 | 35 | |
| 16 | 71 | |
| 17 | 3 | |
| 18 | 16 | |
| 19 | 14 | |
| 20 | 22 |
About Marit Hellebostad
Marit Hellebostad is a scholar working on Hematology, Pediatrics, Perinatology and Child Health and Biochemistry, having authored 37 papers that have together received 929 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (13 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Hematology (413 citations), Pediatrics, Perinatology and Child Health (389 citations) and Public Health, Environmental and Occupational Health (475 citations). Marit Hellebostad has collaborated with scholars based in Norway, Denmark and Sweden. Frequent co-authors include Erik Forestier, Kjeld Schmiegelow, Mats Heyman, S Söderhäll, Mervi Taskinen, Jakob Kristinsson, P Hågå, Ólafur G. Jónsson, Päivi M. Lähteenmäki and P. Mary Cotes. Their work appears in journals such as British Journal of Haematology, Leukemia and Archives of Disease in Childhood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.